Mirati Therapeutics, Inc. was a big mover last session, as its shares rose almost 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up more than 15% in the past one-month time frame.

The company has seen two positive estimate revisions in the last 30 days, while its Zacks Consensus Estimate moved higher over the said time frame, suggesting solid trading ahead. So make sure to keep an eye on this stock going forward to see if this Friday’s jump can turn into more strength down the road.

Mirati Therapeutics currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

Mirati Therapeutics, Inc. Price

 

Mirati Therapeutics, Inc. Price | Mirati Therapeutics, Inc. Quote

A better-ranked stock in the Medical - Biomedical and Genetics space is Alexion Pharmaceuticals, Inc. , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is MRTX going up? Or down? Predict to see what others think: Up or Down

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>